ARTICLE | Company News
Tripos, NovaScreen, Strida in cancer deal
November 9, 2004 8:00 AM UTC
TRPS and NovaScreen (Hanover, Md.) partnered to provide hits against methylenetetrahydrofolate reductase (MTHFR) to Strida (Montreal, Quebec). TRPS will identify and synthesize compounds to be screene...